A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis
Withdrawn before enrolling
Conditions studied: Multiple Sclerosis
In brief
This is a Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis.
Key facts
- Study ID
- NCT01539395
- Run by
- MSDx, Inc.
- People needed
- 0
- Starts
- 2012-01-01
- Expected to finish
- 2012-07-01
- Last updated by the study team
- 2020-09-02
Who can join
Age: 45 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 45 years or older of either gender and of any racial/ethnic group.
- Subjects must be in generally good health.
- Subjects must be able and willing to comply with the requirements of the protocol.
- Must be diagnosed with RRMS
- Meets the criteria to enter Group 1 or Group 2
You may not qualify if…
- Subject is currently in middle of an active episode of an autoimmune condition (e.g. rheumatoid arthritis, system lupus erythematosis)
- Subject currently has a condition such as active influenza that would stimulate the immune system
Where it is running
- Northwest NeuroSpecialists, PLLC — Tucson, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.